COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisKommentar/debatForskningpeer review

DOI

  • Carlo Alviggi, University of Naples Federico II
  • ,
  • Sandro C. Esteves, ANDROFERT, University of Campinas
  • ,
  • Raoul Orvieto, Tel Aviv University, Chaim Sheba Medical Center Israel
  • ,
  • Alessandro Conforti, University of Naples Federico II
  • ,
  • Antonio La Marca, University of Modena and Reggio Emilia
  • ,
  • Robert Fischer, Hamburg Fertility Centre
  • ,
  • Claus Y. Andersen, Københavns Universitet
  • ,
  • Klaus Bühler, Center for Gynecology, Endocrinology and Reproductive Medicine, Scientific-Clinical Centre for Endometriosis of the University Hospitals of Saarland
  • ,
  • Sesh K. Sunkara, King's College London
  • ,
  • Nikolaos P. Polyzos, Dexeus University Hospital
  • ,
  • Ida Strina, University of Naples Federico II
  • ,
  • Luigi Carbone, University of Naples Federico II
  • ,
  • Fabiola C. Bento, ANDROFERT
  • ,
  • Daniela Galliano, Instituto Valenciano de Infertilidad (IVI)
  • ,
  • Hakan Yarali, Anatolia IVF, Ankara, Turkey.
  • ,
  • Lan N. Vuong, University of Medicine and Pharmacy at Ho Chi Minh City, My Duc Hospital
  • ,
  • Michael Grynberg, Universite Paris-Saclay
  • ,
  • Panagiotis Drakopoulos, Vrije Universiteit Brussel, University of Crete
  • ,
  • Pedro Xavier, Hospital Center São João
  • ,
  • Joaquin Llacer, Instituto Bernabeu
  • ,
  • Fernando Neuspiller, Instituto Valenciano de Infertilidad (IVI)
  • ,
  • Marcos Horton, Pregna Medicina Reprodutiva
  • ,
  • Matheus Roque, MATERPRIME, São Paulo, Brazil.
  • ,
  • Evangelos Papanikolaou, Centre of Assisted Reproduction and Genetics, Aristotle University of Thessaloniki
  • ,
  • Manish Banker, Nova IVF Fertility
  • ,
  • Michael H. Dahan, McGill University
  • ,
  • Shu Foong, University of Calgary, Regional Fertility Program
  • ,
  • Herman Tournaye, Vrije Universiteit Brussel
  • ,
  • Christophe Blockeel, Vrije Universiteit Brussel
  • ,
  • Alberto Vaiarelli, Aarhus Universitet
  • ,
  • Peter Humaidan
  • Filippo M. Ubaldi, Aarhus Universitet
  • ,
  • POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) Group

The prolonged lockdown of health services providing high-complexity fertility treatments -as currently recommended by many reproductive medicine entities- is detrimental for society as a whole, and infertility patients in particular. Globally, approximately 0.3% of all infants born every year are conceived using assisted reproductive technology (ART) treatments. By contrast, the total number of COVID-19 deaths reported so far represents approximately 1.0% of the total deaths expected to occur worldwide over the first three months of the current year. It seems, therefore, that the number of infants expected to be conceived and born -but who will not be so due to the lockdown of infertility services- might be as significant as the total number of deaths attributed to the COVID-19 pandemic. We herein propose remedies that include a prognostic-stratification of more vulnerable infertility cases in order to plan a progressive restart of worldwide fertility treatments. At a time when preventing complications and limiting burdens for national health systems represent relevant issues, our viewpoint might help competent authorities and health care providers to identify patients who should be prioritized for the continuation of fertility care in a safe environment.

OriginalsprogEngelsk
Artikelnummer45
TidsskriftReproductive biology and endocrinology : RB&E
Vol/bind18
ISSN1477-7827
DOI
StatusUdgivet - maj 2020

Se relationer på Aarhus Universitet Citationsformater

ID: 188723421